Jafron Biomedical Co Stock

Jafron Biomedical Co Net Margin

The Net Profit Margin of Jafron Biomedical Co (300529.SZ) as of Jul 25, 2026 is 30.63 %. In the previous year, Net Profit Margin was 22.71 % — a change of 34.92% (higher).

Net Margin

30.63 %

YoY

34.92%

Last updated:

Net Profit Margin of Jafron Biomedical Co is 2026 30.63 % . Net Profit Margin of Jafron Biomedical Co was 2025 22.71 % . It decreases by 34.92% higher compared to the previous year.

Jafron Biomedical Co's net margin stands at 30.6%, down from 44.9% several years earlier.

Access this data via the Eulerpool API

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

Net Profit Margin of Jafron Biomedical Co is 30.63 % in 2026.

Access this data via the Eulerpool API

Margins — Jafron Biomedical Co

All Key Metrics — Jafron Biomedical Co